Search research articles
Contact Us
Filters
Showing results (51-60 of 91) with videos related to
Page
of 10
Sort By:
International Journal of Obesity (2005)
|
March 3, 2026
Weight-related changes in MRI-derived measures of body composition and liver steatosis: a large-scale analysis for obesity trial design
Magdalena Nowak, Luis Núñez, Tim Pagliaro, et al.
Obesity (Silver Spring, Md.)
|
October 21, 2022
Obstacles and opportunities in managing coexisting obesity and CKD: Report of a scientific workshop cosponsored by the National Kidney Foundation and The Obesity Society
Allon N Friedman, Philip R Schauer, Srinivasan Beddhu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 24, 2022
Obstacles and Opportunities in Managing Coexisting Obesity and CKD: Report of a Scientific Workshop Cosponsored by the National Kidney Foundation and The Obesity Society
Allon N Friedman, Philip R Schauer, Srinivasan Beddhu, et al.
Diabetes Care
|
August 14, 2016
Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study
Harith Rajagopalan, Alan D Cherrington, Christopher C Thompson, et al.
Population Health Management
|
April 2, 2025
Perspectives on Obesity Management and the Use of Anti-Obesity Medicine from US Employees and Employers: Results from the OBSERVE Study
Jamy Ard, Lee M Kaplan, Scott Kahan, et al.
Nature Medicine
|
June 10, 2024
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
Arun J Sanyal, Lee M Kaplan, Juan P Frias, et al.
Obesity (Silver Spring, Md.)
|
November 4, 2024
Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE™-1 and -2)
Sean Wharton, Carel W le Roux, Mikhail N Kosiborod, et al.
Obesity (Silver Spring, Md.)
|
April 25, 2025
Perceptions of anti-obesity medications among people with obesity and healthcare providers in the US: Findings from the OBSERVE Study
Lee M Kaplan, Kimberly Gudzune, Jamy Ard, et al.
Obesity (Silver Spring, Md.)
|
November 1, 2017
Perceptions of Barriers to Effective Obesity Care: Results from the National ACTION Study
Lee M Kaplan, Angela Golden, Kimberly Jinnett, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 12, 2012
Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery
Ida J Hatoum, Nicholas Stylopoulos, Amanda M Vanhoose, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 91) with videos related to
Sort By:
Page
of 10
International Journal of Obesity (2005)
|
March 3, 2026
Weight-related changes in MRI-derived measures of body composition and liver steatosis: a large-scale analysis for obesity trial design
Magdalena Nowak, Luis Núñez, Tim Pagliaro, et al.
Obesity (Silver Spring, Md.)
|
October 21, 2022
Obstacles and opportunities in managing coexisting obesity and CKD: Report of a scientific workshop cosponsored by the National Kidney Foundation and The Obesity Society
Allon N Friedman, Philip R Schauer, Srinivasan Beddhu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 24, 2022
Obstacles and Opportunities in Managing Coexisting Obesity and CKD: Report of a Scientific Workshop Cosponsored by the National Kidney Foundation and The Obesity Society
Allon N Friedman, Philip R Schauer, Srinivasan Beddhu, et al.
Diabetes Care
|
August 14, 2016
Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study
Harith Rajagopalan, Alan D Cherrington, Christopher C Thompson, et al.
Population Health Management
|
April 2, 2025
Perspectives on Obesity Management and the Use of Anti-Obesity Medicine from US Employees and Employers: Results from the OBSERVE Study
Jamy Ard, Lee M Kaplan, Scott Kahan, et al.
Nature Medicine
|
June 10, 2024
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
Arun J Sanyal, Lee M Kaplan, Juan P Frias, et al.
Obesity (Silver Spring, Md.)
|
November 4, 2024
Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE™-1 and -2)
Sean Wharton, Carel W le Roux, Mikhail N Kosiborod, et al.
Obesity (Silver Spring, Md.)
|
April 25, 2025
Perceptions of anti-obesity medications among people with obesity and healthcare providers in the US: Findings from the OBSERVE Study
Lee M Kaplan, Kimberly Gudzune, Jamy Ard, et al.
Obesity (Silver Spring, Md.)
|
November 1, 2017
Perceptions of Barriers to Effective Obesity Care: Results from the National ACTION Study
Lee M Kaplan, Angela Golden, Kimberly Jinnett, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 12, 2012
Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery
Ida J Hatoum, Nicholas Stylopoulos, Amanda M Vanhoose, et al.
Page
of 10